The editors (both of the Institute of Urology, U. College London, UK) present 18 papers on prostate cancer therapies. They open with chapters on nutrition, lifestyle interventions, and prevention; the current state of biomarkers for prostate cancer; histopathological markers and precursor lesions; and prostate cancer screening. A section on regional prostate cancer includes chapters on assessment of treatment strategies using risk stratification and prediction of clinical outcomes, treatment strategies for low-risk and high-risk cancers, and treatment strategies for biochemical recurrence of prostate cancer. Advanced prostate cancer is the subject of the next section, which includes discussion of hormonal therapy, chemotherapy, molecular strategies and clinical trial design, and therapeutic strategies of palliative care. The final chapters address management of complications, including spinal cord compression and fractures, urinary obstruction, erectile dysfunction, and pain. Published by Clinical Publishing, UK, an imprint of Atlas Medical Publishing Ltd; distributed in the US by BookMasters.